DNA Methylation in Pulmonary Fibrosis
DNA methylations, including global methylation pattern and specific gene methylation, are associated with pathogenesis and progress of pulmonary fibrosis. This chapter illustrates alteration of DNA methylation in pulmonary fibrosis as a predictive or prognostic factor. Treatment with the DNA methylation inhibitors will be an emerging anti-fibrosis therapy, although we are still in the pre-clinical stage of using epigenetic markers as potential targets for biomarkers and therapeutic interventions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:1255 |
---|---|
Enthalten in: |
Advances in experimental medicine and biology - 1255(2020) vom: 19., Seite 51-62 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Shuang [VerfasserIn] |
---|
Links: |
---|
Themen: |
DNA |
---|
Anmerkungen: |
Date Completed 28.09.2020 Date Revised 28.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/978-981-15-4494-1_4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315207639 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315207639 | ||
003 | DE-627 | ||
005 | 20231225154418.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/978-981-15-4494-1_4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1050.xml |
035 | |a (DE-627)NLM315207639 | ||
035 | |a (NLM)32949389 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Shuang |e verfasserin |4 aut | |
245 | 1 | 0 | |a DNA Methylation in Pulmonary Fibrosis |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2020 | ||
500 | |a Date Revised 28.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a DNA methylations, including global methylation pattern and specific gene methylation, are associated with pathogenesis and progress of pulmonary fibrosis. This chapter illustrates alteration of DNA methylation in pulmonary fibrosis as a predictive or prognostic factor. Treatment with the DNA methylation inhibitors will be an emerging anti-fibrosis therapy, although we are still in the pre-clinical stage of using epigenetic markers as potential targets for biomarkers and therapeutic interventions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a DNA | |
650 | 4 | |a IPF | |
650 | 4 | |a Lung fibrosis | |
650 | 4 | |a Methylation | |
650 | 4 | |a Pulmonary fibrosis | |
700 | 1 | |a Wang, Xiangdong |e verfasserin |4 aut | |
700 | 1 | |a Gao, Hongzhi |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Yiming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advances in experimental medicine and biology |d 1971 |g 1255(2020) vom: 19., Seite 51-62 |w (DE-627)NLM000012157 |x 0065-2598 |7 nnns |
773 | 1 | 8 | |g volume:1255 |g year:2020 |g day:19 |g pages:51-62 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-981-15-4494-1_4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 1255 |j 2020 |b 19 |h 51-62 |